Advanced search×

Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.

Yvette R B M YR van Gestel, Sanne E SE Hoeks, Don D DD Sin, Gijs M J M GM Welten, Olaf O Schouten, Han J HJ Witteveen, Cihan C Simsek, Henk H Stam, Frans W FW Mertens, Jeroen J JJ Bax, Ron T RT van Domburg, and Don D Poldermans

Am J Respir Crit Care Med 178(7):695-700 (2008) PMID 18565952

beta-Blocker use is associated with improved health outcomes in patients with cardiovascular disease. There is a general reluctance to prescribe beta-blockers in patients with chronic obstructive pulmonary disease (COPD) because they may worsen symptoms.

DOI: 10.1164/rccm.200803-384OC
Version: za2963e q8za7 q8zba q8zc5 q8zd1 q8zee q8zf7 q8zg8

Similar articles you may find interesting…

  1. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiolo...
    Valentin V Fuster, Lars E LE Rydén, ...

    Europace 8(9):651-745 (2006) PMID 16987906

  2. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary. A report of the American College of C...
    Valentin Fuster, Lars E Ryden, ... Samuel Wann

    Eur Heart J 28(16):2046 (2007)